Navigation Links
AssureRx Health Raises $11 Million Series B Financing
Date:3/25/2011

CINCINNATI, March 25, 2011 /PRNewswire/ -- AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric patients, will use the funds to expand direct sales and marketing for its first product, GeneSightRx®, and for second generation product development activities.

The financing was led by Claremont Creek Ventures and Sequoia Capital and included participation of existing investors Cincinnati Children's Hospital Medical Center, Mayo Clinic and CincyTech, as well as new investor Allos Ventures. John Steuart and Dr. Brad Webb of Claremont Creek Ventures have joined the AssureRx board of directors, increasing board membership to seven.

"Our goal is to build the leading medical informatics company providing pharmacogenetic and other treatment decision support products to help physicians individualize the treatment of patients with neuropsychiatric and other disorders,"  said James S. Burns, president and CEO of AssureRx.  "Claremont Creek and Sequoia bring to AssureRx a wealth of experience and capabilities in informatics, life science, internet marketing, and international business development. Their investment brings substantial strength to our medical informatics platform."

Steuart, managing director of Claremont Creek said, "Venture capital firms such as ours see the opportunity for disruptive change springing from new discoveries in human genetics.  AssureRx has enormous potential as an early leader in the transformation of neuropsychiatric treatment toward individualized patient treatment. GeneSightRx and future treatment decision support products hold the promise for faster, better patient outcomes and less costly care for psychiatric conditions such as clinical depression, anxiety disorder, and schizophrenia."

Warren Hogarth, partner at Sequoia Capital, said, "AssureRx products have the potential to provide significant assistance to physicians worldwide in selecting the appropriate medication for their patients. AssureRx is at the cutting edge of this trend as they address a very large existing market. We look forward to helping them build a world class company."

From a simple cheek swab, the GeneSightRx technology measures and analyzes clinically important genetic variants that determine how a patient's unique genetic make-up affects his or her ability to tolerate or effectively respond to psychotropic medications. Patient-specific genetic information obtained through GeneSightRx can assist physicians in the process of selecting appropriate antidepressant and antipsychotic medications for individual patients.

About Claremont Creek Ventures

Claremont Creek Ventures turbocharges the uncommon startup. As a seed and early stage venture firm, it embraces emerging technologies that accelerate company success, specifically in the healthcare/ IT, energy conservation, and security markets. Utilizing a proprietary life-cycle venturing program, it partners with East-Bay corridor–based entrepreneurs and institutions, including UC Berkeley, Lawrence Livermore Labs and UC Davis. Claremont Creek has more than $300 million in capital under management in two funds. CCV healthcare/IT investments include Gene Security Networks, Fluxion Biosciences, Tibion and Geneweave Biosciences.  For more information, visit www.claremontcreek.com.

About Sequoia Capital

Sequoia Capital provides venture capital funding to founders of startups who want to turn business ideas into enduring companies. As the "Entrepreneurs Behind the Entrepreneurs", Sequoia Capital's Partners have worked with innovators such as Steve Jobs of Apple Computer, Larry Ellison of Oracle, Bob Swanson of Linear Technology, Sandy Lerner and Len Bozack of Cisco Systems, Dan Warmenhoven of NetApp, Jerry Yang and David Filo of Yahoo!, Jen-Hsun Huang of NVIDIA, Michael Marks of Flextronics, Larry Page and Sergey Brin of Google, Chad Hurley and Steve Chen of YouTube, Dominic Orr and Keerti Melkote of Aruba Networks, Jonathan Kaplan of Pure Digital, Tony Hsieh of Zappos, Omar Hamoui of Admob and Steve Streit of Green Dot. To learn more about Sequoia Capital visit www.sequoiacap.com/us/healthcare.

About AssureRx Health

AssureRx Health, Inc. is a personalized medicine company that specializes in pharmacogenetics and is dedicated to helping physicians determine the right drug at the right dose for individual patients suffering from neuropsychiatric and other disorders. The GeneSightRx analysis is based on pharmacogenetics, the study of the genetic factors that influence an individual's response to drug treatments, FDA approved manufacturers' drug labels, scientific and clinical peer-reviewed publications, and proven pharmacology. The company was founded in 2006 to commercialize industry-leading personalized medicine technology. Cincinnati Children's Hospital Medical Center and Mayo Clinic are equity holders and technology collaborators. To learn more about pharmacogenetics and GeneSightRx, please click here.

Contacts:
James S. Burns
President & CEO
AssureRx Health, Inc.
Tel: (513) 234-0510
e-mail: jburns@assurerxhealth.com

Andreas Marathovouniotis or David Schull
Russo Partners
Tel: (212) 845-4235 or (212) 845-4271
e-mail: andreas.marathis@russopartnersllc.com or david.schull@russopartnersllc.com


'/>"/>
SOURCE AssureRx Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AssureRx Appoints Senior Executives in Key Roles to Drive Company Growth
2. AssureRx Expands GeneSightRx® Pharmacogenetic Profile with Sixth Gene to Enhance Guidance of Psychiatric Drug Prescribing
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
5. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Tone Deafness Explained, from the Harvard Health Letter
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
10. ViroPharma to Present at Three Upcoming Healthcare Conferences
11. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , and GAITHERSBURG, Md. , Jan. ... XON ), a leader in the engineering and industrialization of ... the planet, today announced that it has entered into a ... GNVC ), a clinical-stage company and pioneer in the ... intends to integrate and expand upon GenVec,s expertise in adenoviral ...
(Date:1/24/2017)... PUNE, India , January 24, 2017 ... Research, titled, "Acidity Regulators Market - Global Opportunity Analysis ... regulators was valued at $4,456 million in 2015, and is expected ... 7.96% from 2016 to 2022. Asia-Pacific generated ... lead, followed by North America and ...
(Date:1/24/2017)... SEOUL, Korea , Jan. 24, 2017 ... Reddy,s in New Jersey State court alleging that Dr. ... deficiencies in its Food and Drug Administration (FDA) cGMP ... notes that Dr. Reddy,s repeatedly represented to Mezzion that ... hid its misconduct from Mezzion.  The suit also states ...
Breaking Medicine Technology:
(Date:1/24/2017)... , ... January 23, 2017 , ... ... coffee house-caliber protein and espresso drink, announced its CLICK® Coffee Protein Drink is ... CLICK® Coffee Protein Drink Mix has become popular among health-conscious consumers who love ...
(Date:1/24/2017)... ... January 23, 2017 , ... OSF Ventures, ... the world’s largest start-up platform headquartered in Silicon Valley that connects startups to ... Ventures recently signed a three-year agreement to be a corporate sponsor of Plug ...
(Date:1/24/2017)... , ... January 23, 2017 , ... The January 2017 ... a three-year outcome study on how outdoor behavioral healthcare (OBH) – also known as ... and interpersonal difficulties while experiencing an increased sense of purpose both during and after ...
(Date:1/24/2017)... (PRWEB) , ... January 23, 2017 , ... ... analyzed statistics from 140 Buzzies users who entered metrics into the product’s app. ... clinical data. The new data showed that within just 30 seconds of using ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... new plugin that allows sleep centers to automatically connect and initialize all their ... thin client browser plugin is quickly installed on first use and then monitors ...
Breaking Medicine News(10 mins):